A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
While President Trump still refuses to concede and control of the Senate is still technically to be determined, a Biden presidency come January 20th appears…
From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At…
“Given the volatile nature of biotech, many active traders look to the charts of popular exchange-traded products and their top holdings for clues as to…
As the number of those infected with COVID-19 goes up domestically and globally, the competition to develop a vaccine is heating up – and the…
While the authors of today’s article are stock pickers, they argue that there are some situations where exchange-traded funds are the better option – and…
When it comes to the violent swings experienced by the stock market over the last few weeks, the author of today’s article points out that…
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
“Today, you can use ETFs not just to gain quick one-trade exposure to ‘the market,’ but you can also use them for all sorts of…